Overview
- CDC sequencing data estimate NB.1.8.1 makes up about 37% of U.S. COVID-19 cases but acknowledge a wide margin of error due to limited samples
- Genomic analyses trace NB.1.8.1 to late January 2025 as a descendant of Omicron JN.1 with spike protein mutations that boost transmissibility without increasing severity
- Reported symptoms of NB.1.8.1 mirror earlier variants, most commonly including cough, sore throat, fever and fatigue
- CDC continues to recommend COVID-19 vaccination for children aged 6 months and older based on shared decision-making and advises high-risk adults to stay up to date
- FDA plans to authorize updated vaccine boosters for seniors and people with underlying conditions after targeted clinical trials, with broader approvals pending larger studies